Conference Coverage

What’s next for Watchman stroke prevention device


 

EXPERT ANALYSIS FROM THE CARDIOVASCULAR CONFERENCE AT SNOWMASS

References

If such a combined procedure can be done efficiently, it should enable recipients of AF catheter ablation to safely go off oral anticoagulation, noted Dr. Asirvatham, an electrophysiologist who is professor of medicine and pediatrics at the Mayo Clinic, Rochester, Minn.

Dr. Holmes said several small studies of patients who have received combined AF ablation and Watchman implantation have been published.

“It’s uncertain whether left atrial appendage closure will affect AF recurrence rates post ablation, but it should reduce stroke risk. It’s a terribly important field of exploration that will be pursued in registries both in Europe and the United States,” he said.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Primary care endures in heart failure management
MDedge Family Medicine
Heightened emphasis on sex-specific cardiovascular risk factors
MDedge Family Medicine
Therapeutic hypothermia called biggest recent advance in cardiac arrest
MDedge Family Medicine
New ROCKET-AF review claims faulty INR monitoring device didn’t affect results
MDedge Family Medicine
In refractory AF, think weight loss before ablation
MDedge Family Medicine
Compelling case for NOACs in VTE
MDedge Family Medicine
MI, heart failure mortality rates slightly lower in VA hospitals
MDedge Family Medicine
New ACC/AHA guidelines will curb DAPT duration for some
MDedge Family Medicine
Greater myocardial inflammation found in RA patients after heart attack
MDedge Family Medicine
STS: Risk score predicts rehospitalization after heart surgery
MDedge Family Medicine